ANNABIDIOL (ACBD) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 7 13 sessions, February 18, 2025 to February 27, 2026
- Largest daily move
- +2611.5% close of October 20, 2025
- 1-year change
- -43.2% closing prices, February 18, 2025 to February 27, 2026
Company Description
ANNABIDIOL (OTC: ACBD) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $4.0M.
ACBD has declined 43.2% over the past year. The last closing price was $0.8400.
This page collects what Stock Titan holds for ACBD, including price data, latest news, and short interest trends.
Stock Performance
ANNABIDIOL (ACBD) closed at $0.8400 on February 27, 2026. Over the past 12 months, the price has lost 43.2%.
ACBD Metrics & Rankings
Price returns through February 27, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ANNABIDIOL has 3 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, AI. View all ACBD news →
SEC Filings
Short Interest History
Short interest in ANNABIDIOL (ACBD) currently stands at 9 shares. Since October 2025, short interest has decreased by 65.4%.
Days to Cover History
Days to cover for ANNABIDIOL (ACBD) currently stands at 4.5 days, down 99.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 350%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
ACBD Company Profile & Sector Positioning
ANNABIDIOL (ACBD) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC.
Investors comparing ACBD often look at related companies in the same sector, including WELSBACH TECH METALS ACQ (WTMA), MDWERKS INC (MDWK), INCEPTION GROWTH ACQ LTD (IGTA), BREEZE HLDGS ACQ CORP (BRZH), and MOUNTAIN CREST ACQ V (MCAG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ACBD's relative position within its industry.